SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-22-092101
Filing Date
2022-03-31
Accepted
2022-03-31 17:26:27
Documents
15
Period of Report
2022-02-02
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d313550d8ka.htm   iXBRL 8-K/A 28610
2 EX-99.1 d313550dex991.htm EX-99.1 512692
3 EX-99.2 d313550dex992.htm EX-99.2 152465
  Complete submission text file 0001193125-22-092101.txt   972679

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA enviu-20220202.xsd EX-101.SCH 3947
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enviu-20220202_def.xml EX-101.DEF 14539
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE enviu-20220202_lab.xml EX-101.LAB 24063
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enviu-20220202_pre.xml EX-101.PRE 15632
9 EXTRACTED XBRL INSTANCE DOCUMENT d313550d8ka_htm.xml XML 6038
Mailing Address 200 BOSTON AVENUE SUITE 3100 MEDFORD MA 02155
Business Address 200 BOSTON AVENUE SUITE 3100 MEDFORD MA 02155 (617) 616-8188
GreenLight Biosciences Holdings, PBC (Filer) CIK: 0001822691 (see all company filings)

IRS No.: 851914700 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39894 | Film No.: 22794501
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences